News

November 17, 2023

AffyImmune Therapeutics Awarded Best Oncology R&D Advance Scrip Award 2023

October 3, 2023

AffyImmune Therapeutics to Present at 2023 Cell & Gene Meeting on the Mesa

September 21, 2023

AffyImmune Therapeutics Named 2023 Scrip Award Finalist for Best Oncology R&D Advance

May 31, 2023

ASCO 2023 Poster

May 25, 2023

AffyImmune Therapeutics Announces Positive Safety and Early Efficacy Results from Phase 1 Study of AIC100 CAR T Cells in Anaplastic and Advanced Thyroid Cancers at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

September 29, 2022

AffyImmune Therapeutics Adds Serial Entrepreneur Robert Forrester to Board of Directors